Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 6Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Lymphoma, Extranodal NK-T-Cell 3Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, T-Cell 1Leukemia, T-Cell 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

ruxolitinib 1pegaspargase 1nelarabine 1Vincristine 1Panobinostat 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Etoposide 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, T-Cell × pegaspargase × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡